info@allievapharma.com


  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Product Details

    Ibrutinib Capsules 140mg

    Ibrutinib Capsules 140mg


    Brand NameIBRULIEVA 140MG
    CompositionIbrutinib Capsules 140mg
    Manufacture ByAllieva Pharma Private Limited
    FormCapsule
    PackingBtl (30 cap)
    Country Of OriginIndia

    ENQUIRY! Enquire via WhatsApp

    Description

    Description

    IBRULIEVA contains Ibrutinib, a first-generation Bruton’s Tyrosine Kinase (BTK) inhibitor. It blocks BTK signaling in B-cells, thereby inhibiting the growth and survival of malignant B-lymphocytes.

    Uses

    Ibrutinib is indicated for the treatment of:

    1. Chronic Lymphocytic Leukemia (CLL)

    2. Small Lymphocytic Lymphoma (SLL)

    3. Mantle Cell Lymphoma (MCL) – after at least one prior therapy

    4. Waldenström’s Macroglobulinemia

    5. Marginal Zone Lymphoma (MZL) – after prior anti-CD20 therapy

    Side Effects

    Common side effects:

    • Diarrhea

    • Fatigue

    • Muscle and joint pain

    • Nausea

    • Rash

    Hematological:

    • Neutropenia

    • Thrombocytopenia

    • Anemia

    Serious side effects:

    • Bleeding events

    • Atrial fibrillation

    • Severe infections

    • Hypertension

    Dosage

    Dosage varies by indication:

    • CLL/SLL/Waldenström’s: 420 mg once daily

    • MCL/MZL: 560 mg once daily

     Take capsules once daily at the same time, swallow whole with water.
     Can be taken with or without food.


    NOTE: This medicine should be taken only under a doctor’s supervision.

     

    24/7 Clients Support

    Best Price

    Quality Assurance
    function changeImage(elem, src) { document.getElementById("mainImage").src = src; document.querySelectorAll(".thumbnail-container img").forEach(img => img.style.border = "2px solid transparent"); elem.style.border = "2px solid #007bff"; }